Company
ChinaQilu Pharmaceutical Co., Ltd. (Laoling Site), China – FDA Inspections
Inspection records and compliance data for Qilu Pharmaceutical Co., Ltd. (Laoling Site). 1 FDA inspection on record, last inspected August 02, 2024.
Company Profile
This profile covers Qilu Pharmaceutical Co., Ltd. (Laoling Site) based in China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected August 2, 2024.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 2, 2024 | Not classified | Human Drugs | 1249114 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Esteve Huayi Pharmaceutical Co., Ltd.
Suzhou Lixin Pharmaceutical Co. Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Qingdao Jiulong Biopharmaceutical Co. Ltd.
Guangdong Blue Treasure Pharmaceuticals Co. Ltd.
Tien (Tianjin) Pharmaceutical Co., Ltd.
BrightGene Pharmaceutical Co., Ltd.
NANJING HAIRUN PHARMACEUTICAL CO., LTD.
Shandong Lixin Pharmaceutical Co., Ltd.
Nisshin Pharma Inc.
Company Information
Name
Qilu Pharmaceutical Co., Ltd. (Laoling Site)
FEI Number
3026771716
Address
China
Country
China
ID: 78907b17-a53f-49a4-b43b-5484b9883d98